Pricing Log in Create free account
Friday 6 November 2026 Export GMAB’s income statement to Excel — free account

Genmab A/S Sponsored ADR

GMAB Healthcare Biotechnology

Genmab A/S Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 19.2% from fiscal 2024.

Revenue
+24.9%
EPS
−9.26%
Free cash flow
−7.69%

Quarter to June 2026, against a year earlier

53.59 0.85 +1.61%
Market cap
$31.5B
P/E
41.7×
Fwd P/E
47.3×
Dividend yield
—
F-score
4/9
Altman Z
2.78
Beneish M
−3.00
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Genmab A/S Sponsored ADR (GMAB) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Genmab A/S Sponsored ADR (GMAB) trades at a P/B ratio of 5.5×. Over the past ten years it has ranged from 0.7× (February 2019) to 10.5× (September 2019); the current reading is higher than 46% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 3.3× 25.55%
FY2024 2.6× (42.93%)
FY2023 4.6× (36.90%)
FY2022 7.2× (1.16%)
FY2021 7.3× (19.02%)
FY2020 9.0× 35.50%
FY2019 6.7× 728.98%
FY2018 0.8× 0.00%
FY2017 0.8× 0.00%
FY2016 0.8× —

Quarterly newest first

Period P/B ratio Change
Jun 2026 2.8× (5.06%)
Mar 2026 3.0× (9.00%)
Dec 2025 3.3× (0.34%)
Sep 2025 3.3× 36.49%
27 more quarters

Against its own ten years

Low 0.7× High 10.5×
Ten-year median 5.9×
Current reading's percentile 46

P/B ratio against peers

Company P/B ratio
BNTX BioNTech SE Sponsored ADR compare 1.1×
RPRX Royalty Pharma PLC compare 3.1×
INCY Incyte Corporation compare 4.3×
ROIV Roivant Sciences Ltd. compare 5.4×
GMAB Genmab A/S Sponsored ADR 5.5×
ALNY Alnylam Pharmaceuticals, Inc. compare 5.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 7.5×
RVMD Revolution Medicines, Inc. compare 16.1×
INSM Insmed, Inc. compare 32.6×
Biotechnology industry median 2.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on GMAB